CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 

Candel Therapeutics Inc 's Leverage Ratio

CADL's quarterly Leverage Ratio and Total Liabilities, Equity growth




CADL Leverage Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter



Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change - - - - -
Leverage Ratio MRQ 0.09 - - - -
Overall Ranking # 306 # # # #
Seq. Equity Change - - - - -
Seq. Total Liabilities Change -82.86 % - - - -



Leverage Ratio third quarter 2021 Comment
Despite repayements of liabilities of -82.86%, in III. Quarter ,Leverage Ratio detoriated to 0.09, a new company low.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2021, 43 other companies have achieved lower Leverage Ratio than Candel Therapeutics Inc . While Leverage Ratio total ranking has deteriorated compare to previous quarter from to 306.

Explain Leverage Ratio?
Who are CADL Customers?
Leverage Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 161
Overall Market # 306


Leverage Ratio Statistics
High Average Low
0.09 0.09 0.09
(Sep 30 2021)  




Financial Statements
Candel Therapeutics Inc 's Equity $ 63 Millions Visit CADL's Balance sheet
Candel Therapeutics Inc 's Total Liabilities $ 6 Millions Visit CADL's Balance sheet
Source of CADL's Sales Visit CADL's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2021 MRQ Total LiabilitiesSep 30 2021 MRQ Equity
Hydrofarm Holdings Group Inc   0.23 $ 147.994  Millions$ 635.042  Millions
Surface Oncology Inc   0.23 $ 29.989  Millions$ 131.197  Millions
Surrozen Inc   0.22 $ 26.905  Millions$ 123.731  Millions
Aclaris Therapeutics Inc   0.21 $ 46.546  Millions$ 216.581  Millions
Pulmatrix Inc   0.21 $ 9.657  Millions$ 45.193  Millions
Aligos Therapeutics Inc   0.21 $ 46.057  Millions$ 217.011  Millions
Codex Dna Inc   0.21 $ 21.732  Millions$ 102.762  Millions
Brickell Biotech Inc   0.21 $ 4.147  Millions$ 19.968  Millions
Syndax Pharmaceuticals Inc   0.20 $ 40.499  Millions$ 199.004  Millions
Bioatla Inc   0.20 $ 46.926  Millions$ 230.653  Millions
Precipio inc   0.20 $ 5.240  Millions$ 25.917  Millions
Renovacare Inc   0.19 $ 0.670  Millions$ 3.479  Millions
Idera Pharmaceuticals Inc   0.19 $ 6.169  Millions$ 33.011  Millions
Allovir Inc   0.18 $ 49.226  Millions$ 267.304  Millions
Vaxart Inc   0.18 $ 36.188  Millions$ 204.948  Millions
Relay Therapeutics Inc   0.18 $ 100.527  Millions$ 571.088  Millions
Ainos Inc   0.18 $ 3.007  Millions$ 17.136  Millions
Capricor Therapeutics inc   0.17 $ 6.365  Millions$ 36.736  Millions
Talis Biomedical Corporation  0.17 $ 44.304  Millions$ 258.792  Millions
Igm Biosciences Inc   0.16 $ 46.653  Millions$ 285.576  Millions
Homology Medicines Inc  0.16 $ 32.245  Millions$ 198.571  Millions
Ayala Pharmaceuticals Inc   0.16 $ 6.360  Millions$ 39.384  Millions
Petvivo Holdings Inc  0.16 $ 1.366  Millions$ 8.548  Millions
Alpha Teknova Inc   0.16 $ 22.937  Millions$ 146.226  Millions
Revolution Medicines Inc   0.15 $ 96.772  Millions$ 638.204  Millions
89bio Inc   0.15 $ 21.286  Millions$ 146.770  Millions
Caribou Biosciences Inc   0.14 $ 57.559  Millions$ 404.401  Millions
Tscan Therapeutics Inc   0.14 $ 24.404  Millions$ 174.074  Millions
Fortium Holdings Corp   0.13 $ 0.091  Millions$ 0.677  Millions
Protagonist Therapeutics inc   0.13 $ 43.515  Millions$ 329.660  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FOUNU's Profile

Stock Price

FOUNU's Financials

Business Description

Fundamentals

Charts & Quotes

FOUNU's News

Suppliers

FOUNU's Competitors

Customers & Markets

Economic Indicators

FOUNU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071